Social Clips Last Week’s Top-3 Most Read Posts On Scleroderma Last Week’s Top-3 Most Read Posts On Scleroderma by admin | November 23, 2015 Share this article: Share article via email Copy article link Read the Articles Here: Genkyotex’s Systemic Sclerosis Therapy Granted Orphan Drug Designation Mycophenolate Mofitil Identified As Promising Scleroderma-Related Interstitial Lung Disease Treatment Systemic Sclerosis Patients’ Intestinal Microbiome Found To Be Enriched by Inflammatory Bacteria Print This Page Tags Genkyotex, Intestinal Microbiome, mycophenolate mofitil
July 16, 2025 Columns by Tomisa Starr Developing a plan is helpful when dealing with medical uncertainty
July 15, 2025 News by Andrea Lobo, PhD SRF joins capital effort to advance drug development for scleroderma
July 8, 2025 News by Steve Bryson, PhD Scientists ID 4 SSc-ILD subtypes to better predict patient outcomes
